Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNLIP | P16233 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RPS6KA5 | O75582 | 2/20 | 0.44 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.44 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31039840 | 1.00 | PNLIP (0.53) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL19328296 | 1.00 | PNLIP (0.53) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL25667484 | 0.86 | PNLIP (0.53) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL25666955 | 0.86 | PNLIP (0.53) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL30671350 | 0.85 | POLB (0.67) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL13922321 | 0.84 | PNLIP (0.54) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL25269132 | 0.82 | PNLIP (0.56) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL22874145 | 0.82 | PNLIP (0.56) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL22874291 | 0.82 | PNLIP (0.56) | PNLIPPTPN1PTPN2CYP3A4LMNA | |
| SCHEMBL25251393 | 0.82 | PNLIP (0.56) | PNLIPPTPN1PTPN2CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121495734-B | Engineering bacteria and method for synthesizing sclareol | Tianjin Kailaiying Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20250283119-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC (US) | 2025-09-11 | — | — | US | claimed |
| EP-3429641-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-07-03 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| WO-2023212400-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC. (US) | 2023-11-02 | — | — | WO | claimed |
| CN-114921428-B | Baeyer-Villiger monooxygenase and application thereof | 山东大学 | 2023-08-11 | — | — | CN | claimed |
| US-11434448-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2022-09-06 | — | — | US | claimed |
| EP-3861101-A1 | BIOSYNTHESIS AND RECOVERY OF SECONDARY METABOLITES | Manus Bio Inc. (US) | 2021-08-11 | — | — | EP | claimed |
| US-20210040415-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2021-02-11 | — | — | US | claimed |
| US-10899995-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2021-01-26 | — | — | US | claimed |
| WO-2020072908-A1 | BIOSYNTHESIS AND RECOVERY OF SECONDARY METABOLITES | Manus Bio, Inc. (US) | 2020-04-09 | — | — | WO | claimed |
| US-20190345411-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2019-11-14 | — | — | US | claimed |
| US-10407644-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2019-09-10 | — | — | US | claimed |
| EP-3429641-A1 | PERFUME COMPOSITIONS | Givaudan S.A. (CH) | 2019-01-23 | — | — | EP | claimed |
| US-20180100121-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-04-12 | — | — | US | claimed |
| US-9868923-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2018-01-16 | — | — | US | claimed |
| WO-2017157824-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-21 | — | — | WO | claimed |
| US-20170260476-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-14 | — | — | US | claimed |
| WO-2006010390-A1 | NON-IONIC SURFACTANTS AND/OR PERFUME-CONTAINING SODAFREE PARTICLES FOR THE USE IN WASHING AND CLEANING AGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-02 | — | — | WO | claimed |
| CN-121495734-B | Engineering bacteria and method for synthesizing sclareol | Tianjin Kailaiying Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-121495734-B | Engineering bacteria and method for synthesizing sclareol | Tianjin Kailaiying Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| CN-121495734-A | Engineering bacteria and method for synthesizing sclareol | 天津凯莱英生物科技有限公司 | 2026-02-10 | — | — | CN | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250369022-A1 | PRODUCTION OF NATURAL GUM BASE INGREDIENTS BY PLANT CELL FERMENTATION AND APPLICATION THEREOF IN CONFECTIONERY | WM. WRIGLEY JR. COMPANY (US) | 2025-12-04 | — | — | US | disclosed |
| WO-2025231524-A1 | CANNABINOID COMPOSITIONS | Heyday RX Pty Ltd (AU) | 2025-11-13 | — | — | WO | disclosed |
| US-12458619-B2 | Terpene-enriched cannabinoid composition for treatment of male subjects | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2025-11-04 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4615240-A1 | PRODUCTION OF NATURAL GUM BASE INGREDIENTS BY PLANT CELL FERMENTATION AND APPLICATION THEREOF IN CONFECTIONERY | Wm. Wrigley Jr. Company (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250283119-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC (US) | 2025-09-11 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4552652-A2 | TERPENE-ENRICHED CANNABINOID COMPOSITION | Buzzelet Development And Technologies Ltd (IL) | 2025-05-14 | — | — | EP | disclosed |
| EP-4549538-A2 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2025-05-07 | — | — | EP | disclosed |
| US-12291684-B2 | Method embodiments for partial hydrogenation of carbocyclic compounds to produce jet fuel blendstock | BATTELLE MEMORIAL INSTITUTE (US) | 2025-05-06 | — | — | US | disclosed |
| EP-3387096-B1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-02-19 | — | — | EP | disclosed |
| WO-2025030248-A1 | CANNABINOID EMULSION | BLACK & BLUE FOODS INC. (CA) | 2025-02-13 | — | — | WO | disclosed |
| US-20250011735-A1 | RECOMBINANT POLYPRENOL DIPHOSPHATE SYNTHASES | CB THERAPEUTICS, INC. (US) | 2025-01-09 | — | — | US | disclosed |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | ALKALAY RACHEL (IL) | 2024-11-28 | — | — | US | disclosed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-112074736-B | UV filter composition, method for the production thereof and use thereof | 巴斯夫欧洲公司 | 2024-10-01 | — | — | CN | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240261304-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATING CONDITIONS AND/ OR SYMPTOMS ASSOCIATED WITH A STRESSFUL EVENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2024-08-08 | — | — | US | disclosed |
| US-20240245743-A1 | USE OF CINNAMOMUM ZEYLANICUM ESSENTIAL OIL (EO) AS HUMAN MELANOMA CELLS DEATH INDUCER AND AS POSSIBLE ADJUVANT IN PHARMACOLOGICAL THERAPIES | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2024-07-25 | — | — | US | disclosed |
| US-20240226218-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | Novel Concepts Medical Ltd (IL) | 2024-07-11 | — | — | US | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| EP-3429641-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-20240207342-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207343-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207344-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024102626-A1 | PRODUCTION OF NATURAL GUM BASE INGREDIENTS BY PLANT CELL FERMENTATION AND APPLICATION THEREOF IN CONFECTIONERY | WM. WRIGLEY JR. COMPANY (US) | 2024-05-16 | — | — | WO | disclosed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| US-20240124905-A1 | Recombinant Polyprenol Diphosphate Synthases | CB THERAPEUTICS INC (US) | 2024-04-18 | — | — | US | disclosed |
| US-20240108676-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-04-04 | — | — | US | disclosed |
| US-20240099987-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2024-03-28 | — | — | US | disclosed |
| US-11925652-B2 | Terpene-enriched cannabinoid composition and method of treatment | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2024-03-12 | — | — | US | disclosed |
| WO-2024044063-A1 | PRODUCING SEMI-CRYSTALLINE POLYCARBONATE AND USE THEREOF IN ADDITIVE MANUFACTURING | JABIL, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-3310893-B2 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| CN-117604043-A | Production of minol | 弗门尼舍有限公司 | 2024-02-27 | — | — | CN | disclosed |
| US-11891640-B1 | Crop protection in algae by exogenous terpene expression | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2024-02-06 | — | — | US | disclosed |
| US-11883454-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230405067-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2023-12-21 | — | — | US | disclosed |
| CN-110100003-B | Production of Minol | 弗门尼舍有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-20230346866-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE | Novel Concepts Medical Ltd (IL) | 2023-11-02 | — | — | US | disclosed |
| WO-2023212400-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| US-20230346739-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-11-02 | — | — | US | disclosed |
| US-20230293480-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-20230293555-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| CN-114921428-B | Baeyer-Villiger monooxygenase and application thereof | 山东大学 | 2023-08-11 | — | — | CN | disclosed |
| US-20230248746-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-08-10 | — | — | US | disclosed |
| US-20230248691-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-08-10 | — | — | US | disclosed |
| US-11684604-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230193148-A1 | METHOD EMBODIMENTS FOR PARTIAL HYDROGENATION OF CARBOCYCLIC COMPOUNDS TO PRODUCE JET FUEL BLENDSTOCK | BATTELLE MEMORIAL INSTITUTE (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230181665-A1 | TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES | Novel Concepts Medical Ltd (IL) | 2023-06-15 | — | — | US | disclosed |
| US-20230134432-A1 | COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS AND PROLIFERATIVE DISEASES | Novel Concepts Medical Ltd (IL) | 2023-05-04 | — | — | US | disclosed |
| US-11628156-B2 | Terpene-enriched cannabinoid composition and method of treatment | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-04-18 | — | — | US | disclosed |
| US-11566265-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
| EP-3317418-B1 | PRODUCTION OF MANOOL | FIRMENICH & CIE (CH) | 2022-11-30 | — | — | EP | disclosed |
| US-11478433-B2 | Nanomaterials with enhanced drug delivery efficiency | YALE UNIVERSITY (US) | 2022-10-25 | — | — | US | disclosed |
| US-20220323371-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-10-13 | — | — | US | disclosed |
| US-11434448-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2022-09-06 | — | — | US | disclosed |
| CN-114921428-A | Baeyer-Villiger monooxygenase and application thereof | 山东大学 | 2022-08-19 | — | — | CN | disclosed |
| WO-2022164870-A1 | RECOMBINANT POLYPRENOL DIPHOSPHATE SYNTHASES | CB THERAPEUTICS, INC. (US) | 2022-08-04 | — | — | WO | disclosed |
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-20220168230-A1 | NANOPARTICLE MEDIATED THERAPY | YALE UNIVERSITY | 2022-06-02 | — | — | US | disclosed |
| US-11332693-B2 | Organic compounds | GIVAUDAN SA (CH) | 2022-05-17 | — | — | US | disclosed |
| US-20220000764-A1 | STABILIZED TERPENE-ENRICHED CANNABINOID EXTRACT AND METHODS OF USE THEREOF | COLUMBIA CARE LLC | 2022-01-06 | — | — | US | disclosed |
| EP-3917505-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT FOR TREATING CONDITIONS AND/OR SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER | Buzzelet Development And Technologies Ltd (IL) | 2021-12-08 | — | — | EP | disclosed |
| US-20210353638-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATING CONDITIONS ASSOCIATED WITH AUTISM OR AUTISM SPECTRUM DISORDER | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-11-18 | — | — | US | disclosed |
| US-20210340577-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-11-04 | — | — | US | disclosed |
| EP-3902538-A1 | ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF | Buzzelet Development And Technologies Ltd (IL) | 2021-11-03 | — | — | EP | disclosed |
| EP-3902553-A1 | HERBAL PREPARATION-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | Buzzelet Development And Technologies Ltd (IL) | 2021-11-03 | — | — | EP | disclosed |
| US-20210322366-A1 | HERBAL PREPARATION-ENRICHED CANNABINOID COMPOSITION AND METHODS OF TREATMENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-10-21 | — | — | US | disclosed |
| US-20210322367-A1 | ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-10-21 | — | — | US | disclosed |
| US-20210317341-A1 | ADHESIVE COMPOSITION COMPRISING BLOCK COPOLYMER WITH POLYVINYL AROMATIC ENDBLOCK AND POLY(VINYL AROMATIC/BUTADIENE) COPOLYMER BLOCK AND SIS BLOCK COPOLYMER, ARTICLES, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2021-10-14 | — | — | US | disclosed |
| EP-3876903-A1 | STABILIZED TERPINE-ENRICHED CANNABINOID EXTRACT AND METHODS OF USE THEREOF | Columbia Care LLC (US) | 2021-09-15 | — | — | EP | disclosed |
| CN-107889506-B | Production of manool | 弗门尼舍有限公司 | 2021-09-14 | — | — | CN | disclosed |
| EP-3864102-A1 | ADHESIVE COMPOSITION COMPRISING BLOCK COPOLYMER WITH POLYVINYL AROMATIC ENDBLOCK AND POLY(VINYL AROMATIC/BUTADIENE) COPOLYMER BLOCK AND SIS BLOCK COPOLYMER, ARTICLES, AND METHODS | 3M Innovative Properties Company (US) | 2021-08-18 | — | — | EP | disclosed |
| EP-3861101-A1 | BIOSYNTHESIS AND RECOVERY OF SECONDARY METABOLITES | Manus Bio Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| US-11072805-B2 | Two-phase fermentation process for the production of an organic compound | ISOBIONICS B.V. | 2021-07-27 | — | — | US | disclosed |
| US-20210207078-A1 | BIOSYNTHESIS AND RECOVERY OF SECONDARY METABOLITES | MANUS BIO INC. | 2021-07-08 | — | — | US | disclosed |
| US-11041175-B2 | — | — | 2021-06-22 | — | — | US | disclosed |
| US-11028413-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-08 | — | — | US | disclosed |
| US-20210128522-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATMENT OF MALE SUBJECTS | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-05-06 | — | — | US | disclosed |
| EP-3793542-A2 | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND USES THEREOF IN THE TREATMENT OF INFECTIOUS CONDITIONS | Buzzelet Development And Technologies Ltd (IL) | 2021-03-24 | — | — | EP | disclosed |
| US-10947563-B2 | Terpene synthases for biofuel production and methods thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2021-03-16 | — | — | US | disclosed |
| US-20210059978-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND USES THEREOF IN THE TREATMENT OF INFECTIOUS CONDITIONS | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-03-04 | — | — | US | disclosed |
| EP-3781140-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATING CONDITIONS AND/ OR SYMPTOMS ASSOCIATED WITH A STRESSFUL EVENT | Buzzelet Development And Technologies Ltd (IL) | 2021-02-24 | — | — | EP | disclosed |
| US-20210040415-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2021-02-11 | — | — | US | disclosed |
| US-20210023045-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATING CONDITIONS AND/ OR SYMPTOMS ASSOCIATED WITH A STRESSFUL EVENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2021-01-28 | — | — | US | disclosed |
| US-20210023044-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2021-01-28 | — | — | US | disclosed |
| US-10899995-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2021-01-26 | — | — | US | disclosed |
| US-20210010035-A1 | PRODUCTION OF MANOOL | FIRMENICH & CIE (CH) | 2021-01-14 | — | — | US | disclosed |
| US-10806683-B2 | Encapsulated perfume compositions | GIVAUDAN SA (CH) | 2020-10-20 | — | — | US | disclosed |
| US-20200283803-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3017050-B1 | TWO-PHASE FERMENTATION PROCESS FOR THE PRODUCTION OF AN ISOPRENOID | Isobionics Bv (NL) | 2020-09-09 | — | — | EP | disclosed |
| US-10752922-B2 | Production of manool | FIRMENICH SA (CH) | 2020-08-25 | — | — | US | disclosed |
| US-20200261404-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-08-20 | — | — | US | disclosed |
| US-20200253919-A1 | TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-08-13 | — | — | US | disclosed |
| WO-2020157639-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT FOR TREATING CONDITIONS AND/OR SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-08-06 | — | — | WO | disclosed |
| EP-3310893-B1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2020-08-05 | — | — | EP | disclosed |
| US-10722857-B2 | Encapsulated perfume compositions | GIVAUDAN S.A. (CH) | 2020-07-28 | — | — | US | disclosed |
| US-20200214989-A1 | NANOMATERIALS WITH ENHANCED DRUG DELIVERY EFFICIENCY | YALE UNIVERSITY | 2020-07-09 | — | — | US | disclosed |
| WO-2020136627-A1 | ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-07-02 | — | — | WO | disclosed |
| WO-2020136593-A1 | HERBAL PREPARATION-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-07-02 | — | — | WO | disclosed |
| EP-2900679-B1 | 5-FLUOROURIDINE DERIVATIVES | BRAUN MELSUNGEN AG (DE) | 2020-07-01 | — | — | EP | disclosed |
| EP-3664796-A2 | TERPENE-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT | Buzzelet Development And Technologies Ltd (IL) | 2020-06-17 | — | — | EP | disclosed |
| EP-3644976-A2 | TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH | Buzzelet Development And Technologies Ltd (IL) | 2020-05-06 | — | — | EP | disclosed |
| US-10633675-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-04-28 | — | — | US | disclosed |
| WO-2020072908-A1 | BIOSYNTHESIS AND RECOVERY OF SECONDARY METABOLITES | Manus Bio, Inc. (US) | 2020-04-09 | — | — | WO | disclosed |
| US-10561731-B2 | Method and compositions for solubilizing non-polar constituents | ENTOURAGE BIOSCIENCE LLC (US) | 2020-02-18 | — | — | US | disclosed |
| US-20200037638-A1 | FORMULATIONS | ACQUIOM AGENCY SERVICES LLC | 2020-02-06 | — | — | US | disclosed |
| US-10537868-B2 | Microcapsules | GIVAUDAN S.A. (CH) | 2020-01-21 | — | — | US | disclosed |
| WO-2020012315-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATMENT OF MALE SUBJECTS | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2020-01-16 | — | — | WO | disclosed |
| US-20190352673-A1 | PRODUCTION OF MANOOL | FIRMENICH SA (CH) | 2019-11-21 | — | — | US | disclosed |
| US-20190345411-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2019-11-14 | — | — | US | disclosed |
| US-20190328883-A1 | METHOD AND COMPOSITIONS FOR SOLUBILIZING NON-POLAR CONSTITUENTS | ENTOURAGE BIOSCIENCE LLC (US) | 2019-10-31 | — | — | US | disclosed |
| EP-3559245-A2 | PRODUCTION OF MANOOL | Firmenich SA (CH) | 2019-10-30 | — | — | EP | disclosed |
| EP-3310892-B1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2019-10-23 | — | — | EP | disclosed |
| WO-2019198056-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATING CONDITIONS AND/ OR SYMPTOMS ASSOCIATED WITH A STRESSFUL EVENT | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2019-10-17 | — | — | WO | disclosed |
| US-20190298833-A1 | METHOD AND COMPOSITIONS FOR SOLUBILIZING NON-POLAR CONSTITUENTS | ENTOURAGE BIOSCIENCE LLC (US) | 2019-10-03 | — | — | US | disclosed |
| US-10407644-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2019-09-10 | — | — | US | disclosed |
| US-10400254-B1 | Terpene synthases for biofuel production and methods thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2019-09-03 | — | — | US | disclosed |
| US-10385361-B2 | Production of manool | FIRMENICH SA (CH) | 2019-08-20 | — | — | US | disclosed |
| US-10376586-B2 | Method and compositions for solubilizing non-polar constituents | ENTOURAGE BIOSCIENCE LLC (US) | 2019-08-13 | — | — | US | disclosed |
| CN-110100003-A | Production of manool | 弗门尼舍有限公司 | 2019-08-06 | — | — | CN | disclosed |
| US-20190225994-A1 | TWO-PHASE FERMENTATION PROCESS FOR THE PRODUCTION OF AN ORGANIC COMPOUND | ISOBIONICS B.V. (NL) | 2019-07-25 | — | — | US | disclosed |
| EP-2900681-B1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPOPHILIC NUCLEOSIDES | IONOVATION GMBH (DE) | 2019-07-10 | — | — | EP | disclosed |
| US-20190175633-A1 | REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS | IONOVATION GMBH (DE) | 2019-06-13 | — | — | US | disclosed |
| EP-3429580-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | Buzzelet Development And Technologies Ltd (IL) | 2019-01-23 | — | — | EP | disclosed |
| EP-3429641-A1 | PERFUME COMPOSITIONS | Givaudan S.A. (CH) | 2019-01-23 | — | — | EP | disclosed |
| US-20190017077-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-01-17 | — | — | US | disclosed |
| WO-2019003163-A2 | TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. (IL) | 2019-01-03 | — | — | WO | disclosed |
| US-20190002925-A1 | PRODUCTION OF MANOOL | FIRMENICH SA (CH) | 2019-01-03 | — | — | US | disclosed |
| WO-2018237109-A1 | NANOMATERIALS WITH ENHANCED DRUG DELIVERY EFFICIENCY | YALE UNIVERSITY (US) | 2018-12-27 | — | — | WO | disclosed |
| US-20180371359-A1 | Improvement In or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2018-12-27 | — | — | US | disclosed |
| EP-3416729-A1 | PRO-FRAGRANCE COMPOSITION | Aqdot Limited (GB) | 2018-12-26 | — | — | EP | disclosed |
| CN-108778349-A | Spice composition | 奇华顿股份有限公司 | 2018-11-09 | — | — | CN | disclosed |
| EP-3387096-A1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2018-10-17 | — | — | EP | disclosed |
| US-20180282766-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-10-04 | — | — | US | disclosed |
| WO-2018152334-A1 | FORMULATIONS | MOLECULAR INFUSIONS, LLC (US) | 2018-08-23 | — | — | WO | disclosed |
| CN-108368450-A | In organic compound or associated improvement | 奇华顿股份有限公司 | 2018-08-03 | — | — | CN | disclosed |
| US-20180185808-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2018-07-05 | — | — | US | disclosed |
| WO-2018114839-A2 | PRODUCTION OF MANOOL | FIRMENICH SA (CH) | 2018-06-28 | — | — | WO | disclosed |
| US-20180177689-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-28 | — | — | US | disclosed |
| US-20180169035-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2018-06-21 | — | — | US | disclosed |
| US-20180169603-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-21 | — | — | US | disclosed |
| EP-3316972-A1 | MICROCAPSULES | Givaudan S.A. (CH) | 2018-05-09 | — | — | EP | disclosed |
| EP-3317418-A1 | PRODUCTION OF MANOOL | Firmenich SA (CH) | 2018-05-09 | — | — | EP | disclosed |
| US-9957527-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-05-01 | — | — | US | disclosed |
| EP-3310892-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | Givaudan SA (CH) | 2018-04-25 | — | — | EP | disclosed |
| EP-3310893-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | Givaudan SA (CH) | 2018-04-25 | — | — | EP | disclosed |
| EP-2900273-B1 | COLLOID BONDED MEDICINAL COMPOUNDS | BRAUN MELSUNGEN AG (DE) | 2018-04-18 | — | — | EP | disclosed |
| US-20180100121-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-04-12 | — | — | US | disclosed |
| CN-107889506-A | The production of manool | 弗门尼舍有限公司 | 2018-04-06 | — | — | CN | disclosed |
| US-9902752-B2 | 5-fluorouracil derivatives | B. BRAUN MELSUNGEN AG (DE) | 2018-02-27 | — | — | US | disclosed |
| US-9868923-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2018-01-16 | — | — | US | disclosed |
| WO-2017157824-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-21 | — | — | WO | disclosed |
| WO-2017158539-A1 | TERPENE-ENRICHED CANNABINOID COMPOSITION | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2017-09-21 | — | — | WO | disclosed |
| US-20170260476-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2017-09-14 | — | — | US | disclosed |
| WO-2017141030-A1 | PRO-FRAGRANCE COMPOSITION | AQDOT LIMITED (GB) | 2017-08-24 | — | — | WO | disclosed |
| US-9737613-B2 | Colloid bonded medicinal compounds | B. BRAUN MELSUNGEN AG (DE) | 2017-08-22 | — | — | US | disclosed |
| US-20170232105-A1 | METHOD AND COMPOSITIONS FOR SOLUBILIZING NON-POLAR CONSTITUENTS | ENTOURAGE BIOSCIENCE LLC (US) | 2017-08-17 | — | — | US | disclosed |
| WO-2017097972-A1 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2017-06-15 | — | — | WO | disclosed |
| US-20170002382-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-01-05 | — | — | US | disclosed |
| WO-2017001641-A1 | PRODUCTION OF MANOOL | FIRMENICH S.A. (CH) | 2017-01-05 | — | — | WO | disclosed |
| WO-2017001672-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2017-01-05 | — | — | WO | disclosed |
| WO-2016207179-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-12-29 | — | — | WO | disclosed |
| WO-2016207180-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-12-29 | — | — | WO | disclosed |
| US-9404130-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160168595-A1 | TWO-PHASE FERMENTATION PROCESS FOR THE PRODUCTION OF AN ORGANIC COMPOUND | ISOBIONICS B.V. (NL) | 2016-06-16 | — | — | US | disclosed |
| US-9358191-B2 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| EP-3017050-A1 | TWO-PHASE FERMENTATION PROCESS FOR THE PRODUCTION OF AN ORGANIC COMPOUND | Isobionics B.V. (NL) | 2016-05-11 | — | — | EP | disclosed |
| WO-2015195602-A1 | STRETCH RELEASABLE PRESSURE SENSITIVE ADHESIVE COMPOSITIONS AND ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015195620-A1 | PEEL RELEASE PRESSURE SENSITIVE ADHESIVE COMPOSITIONS AND ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015195616-A1 | ADHESIVE TAPE BEARING A PRESSURE-SENSITIVE ADHESIVE THAT COMPRISES A POLAR PHENOLIC TACKIFIER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-23 | — | — | WO | disclosed |
| US-20150291649-A1 | 5-Fluorouracil Derivatives | B. BRAUN MELSUNGEN AG (DE) | 2015-10-15 | — | — | US | disclosed |
| US-20150240295-A1 | REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS | IONOVATION GMBH (DE) | 2015-08-27 | — | — | US | disclosed |
| EP-2900273-A1 | COLLOID BONDED MEDICINAL COMPOUNDS | B. Braun Melsungen AG (DE) | 2015-08-05 | — | — | EP | disclosed |
| EP-2900681-A1 | REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS | Ionovation GmbH (DE) | 2015-08-05 | — | — | EP | disclosed |
| EP-2900679-A1 | 5-FLUORUORACIL DERIVATIVES | B. Braun Melsungen AG (DE) | 2015-08-05 | — | — | EP | disclosed |
| US-20150202307-A1 | Colloid Bonded Medicinal Compounds | B. BRAUN MELSUNGEN AG (DE) | 2015-07-23 | — | — | US | disclosed |
| US-20150203404-A1 | Powder Mixture And Process To Make Dry Mortar | AKZO NOBEL CHEMICALS INT BV (NL) | 2015-07-23 | — | — | US | disclosed |
| WO-2015089811-A1 | FRAGRANCE | GIVAUDAN SA (CH) | 2015-06-25 | — | — | WO | disclosed |
| CN-104730031-A | Method for determining chemical components of rosin by using near infrared spectrum technology | RES INST SUBTROPICAL FORESTRY CAF | 2015-06-24 | — | — | CN | disclosed |
| US-20150152446-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2015-06-04 | — | — | US | disclosed |
| EP-2872461-A2 | POWDER MIXTURE AND PROCESS TO MAKE DRY MORTAR | Akzo Nobel Chemicals International B.V. (NL) | 2015-05-20 | — | — | EP | disclosed |
| WO-2015002528-A1 | TWO-PHASE FERMENTATION PROCESS FOR THE PRODUCTION OF AN ORGANIC COMPOUND | ISOBIONICS B.V. (NL) | 2015-01-08 | — | — | WO | disclosed |
| US-8927241-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-01-06 | — | — | US | disclosed |
| US-20140271522-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-09-18 | — | — | US | disclosed |
| US-8778320-B2 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-1561476-B1 | DEODORANT COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2014-02-12 | — | — | EP | disclosed |
| WO-2014009299-A2 | POWDER MIXTURE AND PROCESS TO MAKE DRY MORTAR | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2014-01-16 | — | — | WO | disclosed |
| US-20130302861-A1 | EXPRESSION CONSTRUCTS AND USES THEREOF IN THE PRODUCTION OF TERPENOIDS IN YEAST | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-11-14 | — | — | US | disclosed |
| EP-2618856-A1 | DEODORANT COMPOSITION FOR SULFIDES | Takasago International Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| CN-103189076-A | Deodorant composition for sulfides | TAKASAGO PERFUMERY CO LTD | 2013-07-03 | — | — | CN | disclosed |
| US-20130136713-A1 | DEODORANT COMPOSITION FOR SULFIDES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-05-30 | — | — | US | disclosed |
| US-20120107893-A1 | MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-05-03 | — | — | US | disclosed |
| WO-2012039516-A1 | DEODORANT COMPOSITION FOR SULFIDES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-03-29 | — | — | WO | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| WO-2006010390-A1 | NON-IONIC SURFACTANTS AND/OR PERFUME-CONTAINING SODAFREE PARTICLES FOR THE USE IN WASHING AND CLEANING AGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-02 | — | — | WO | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684604-B2 | Cannabis based therapeutic and method of use | CNR2, CNR1, OPRK1 | PNLIP 583/4885PTPN1 2536/4885PTPN2 2124/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | PNLIP 68/4885PTPN1 1893/4885PTPN2 2364/4885 |
| US-20240390446-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES AND THYROID DISEASES | TPO, TNF, ADAMTS13 | PNLIP 111/4885PTPN1 1879/4885PTPN2 1841/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | PNLIP 2042/4885PTPN1 4282/4885PTPN2 4037/4885 |
| US-20150202307-A1 | Colloid Bonded Medicinal Compounds | ALB, EPCAM, SERPINA6 | PNLIP 1632/4885PTPN1 4469/4885PTPN2 4138/4885 |
| US-11478433-B2 | Nanomaterials with enhanced drug delivery efficiency | VIP, SI, LSS | PNLIP 12/4885PTPN1 3394/4885PTPN2 3700/4885 |
| US-20200214989-A1 | NANOMATERIALS WITH ENHANCED DRUG DELIVERY EFFICIENCY | VIP, SI, LSS | PNLIP 11/4885PTPN1 3385/4885PTPN2 3706/4885 |
| US-20150291649-A1 | 5-Fluorouracil Derivatives | DPYD, FAU, DHFR | PNLIP 1943/4885PTPN1 3547/4885PTPN2 3198/4885 |
| US-20150240295-A1 | REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS | NCL, NOP2, POLRMT | PNLIP 1034/4885PTPN1 4801/4885PTPN2 4737/4885 |
| US-20220168230-A1 | NANOPARTICLE MEDIATED THERAPY | LSS, CYP46A1, CYP51A1 | PNLIP 1287/4885PTPN1 1988/4885PTPN2 3192/4885 |
| US-20210023044-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR2, CNR1, OPRK1 | PNLIP 583/4885PTPN1 2536/4885PTPN2 2124/4885 |
| US-20190175633-A1 | REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS | NCL, NOP2, HNRNPD | PNLIP 246/4885PTPN1 4832/4885PTPN2 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.